Jane Street
AEON icon

Jane Street’s AEON Biopharma AEON Stock Holding History

Jane Street’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.1K Buy
+16,376
New +$18.3K ﹤0.01% 11233
2025
Q4 		– Sell
-10,420
Closed -$8.43K – 10980
2025
Q3 		$8.43K Buy
+10,420
New +$8.03K ﹤0.01% 10587
2025
Q1 		– Sell
-153
Closed -$5.95K – 9305
2024
Q4 		$5.95K Buy
153
+4
+3% +$233 ﹤0.01% 9213
2024
Q3 		$11.2K Sell
149
-174
-54% -$15.3K ﹤0.01% 9344
2024
Q2 		$24.4K Sell
323
-180
-36% -$42.9K ﹤0.01% 9024
2024
Q1 		$421K Buy
+503
New +$364K ﹤0.01% 6990

Other funds holding AEON

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jane Street's AEON Position: Q1 2026 in Review

Jane Street opened a new position in AEON Biopharma (AEON) in Q1 2026: 16,376 shares worth $16.1K. The stake represents ﹤0.01% of the portfolio and ranks #11233 among its holdings. This is a return to the name: Jane Street previously reported a position in AEON as recently as Q3 2025.

Jane Street first reported a position in AEON in Q1 2024 and has held it in 6 quarters since. The position peaked at $421K in Q1 2024. 24 funds tracked by Wall St. Rank hold AEON as of Q1 2026.

  • Jane Street held 16,376 shares of AEON Biopharma worth $16.1K as of Q1 2026.
  • AEON Biopharma was a new Jane Street position in Q1 2026.
  • AEON Biopharma made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #11233 holding.
  • Jane Street first reported a position in AEON Biopharma in Q1 2024 and has held it in 6 quarters since.
  • Jane Street's AEON Biopharma position peaked at $421K in Q1 2024.
  • 24 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.